Eads & Heald Wealth Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $308K | Sell |
|
|||||
|
2024
Q4 | $322K | Sell |
|
|||||
|
2024
Q3 | $297K | Hold |
|
|||||
|
2024
Q2 | $243K | Sell |
|
|||||
|
2024
Q1 | $282K | Buy |
|
|||||
|
2023
Q4 | $286K | Sell |
|
|||||
|
2023
Q3 | $269K | Sell |
|
|||||
|
2023
Q2 | $277K | Sell |
|
|||||
|
2023
Q1 | $307K | Buy |
|
|||||
|
2022
Q4 | $286K | Sell |
|
|||||
|
2022
Q3 | $270K | Buy |
|
|||||
|
2022
Q2 | $238K | Buy |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $321K | Buy |
|
|||||
|
2021
Q3 | $306K | Buy |
|
|||||
|
2021
Q2 | $230K | Buy |
|
|||||
|
2021
Q1 | $201K | Buy |
|
|||||
|
2020
Q4 | – | Sell |
|
|||||
|
2020
Q3 | $204K | Buy |
|
|||||
|
2016
Q4 | – | Sell |
|
|||||
|
2016
Q3 | $353K | Sell |
|
|||||
|
2016
Q2 | $614K | Sell |
|
|||||
|
2016
Q1 | $689K | Sell |
|
|||||
|
2015
Q4 | $770K | Sell |
|
|||||
|
2015
Q3 | $801K | Buy |
|
|||||
|
2015
Q2 | $906K | Buy |
|
|||||
|
2015
Q1 | $363K | Buy |
|
|||||
|
2014
Q4 | $266K | Buy |
|